G
Goldman Sachs Alternatives
Acquirer counsel
Latham & Watkins
Robbie McLarenPartner
Giovanni B. SandicchiPartner
25 lawyers involved
Rainmaker
Loading page...
Goldman Sachs Alternatives acquires majority stake in Numantec from White Bridge Investments $update-09-22
Deal Overview
- Value
- €700mUS$797.23m · Reported
- Deal type
- M&A
- Structure
- Majority stakePrivate Equity
- Status
- Signed27 Jul 2026
Advisors
ACQUIRER
Latham & Watkins Overview
- Acquirer: Goldman Sachs Alternatives, through the Private Equity business of Goldman Sachs Asset Management; the buyer entity in the legal-press reports is Goldman Sachs Asset Management International.
- Acquiring: a majority stake in Numantec from White Bridge Investments and other existing shareholders. Terms were not disclosed; Reuters reported that the sale valued Numantec at around EUR 700 million (c.US$797 million at the 27 July 2026 ECB rate), citing a person with knowledge of the matter, and the parties have not confirmed a figure.
- Rationale: back Numantec's above-market growth, broad product portfolio and acquisition track record, and partner with management to scale the manufacturing footprint and product range, add and develop products and expand into new geographies and channels.
- Acquirer counsel: Latham & Watkins, led by London corporate partner Robbie McLaren (with associates Antonina Semyachkova and Ella Higgins) and Milan corporate partner Giovanni Sandicchi (with associates Gianluca Volpato, Nicola Occhipinti and Filippo Bernasconi). Healthcare and life sciences: Eveline Van Keymeulen, Jeanne Fabre, Alexis Vaujany. Digital transformation: Oliver Mobasser, Clarence Cheong. Corporate (US, Germany, France): Todd Gleason, Kim Springstead-Chen, Sophie Thieme, Julien Zeitoun, Tobias Derlot. Anti-bribery / FCPA: Clare Nida, Erin Brown Jones, Stefan Bartz, Annie Birch, Daniele Isidoro. ESG: Michael Green, James Bee. Sanctions and export controls: Thomas Lane, Ruchi Gill, Matthew Crawford, Gregory Slevin. Tax: Sean Finn, Alan Kimball.
- Italian co-counsel to the acquirer: LMS, led by partners Fabio Labruna and Fabio Niccoli with Elisabetta Russo, Marco Romeo, Nicolò Levati, Clara Pettoello and Federica Conforti (corporate); Mario Lisanti and Davide Cipolletta (banking); Ludovico Anselmi and Isabella Austoni (IP).
- Acquisition financing: A&O Shearman advised Goldman Sachs Alternatives on the financing, led by partners Robin Harvey, Adam Zecharia (London) and Diego Esposito (Milan) with Dhruv Mairal, Irfan Mallam-Hassam, Alessia Cellucci and Sofia Campa; tax: Elia Ferdinando Clarizia. Linklaters advised the financing banks, coordinated by partner Pathik Gandhi with Marco Carrieri, Maria Chiara De Biasio and Giulia Maria Fasano; capital markets: Linda Taylor; tax: Fabio Balza, Luigi Spinello.
- Other acquirer advisers: Goldman Sachs International (investment banking); Bain, Deloitte, Ramboll, QServe and Aon (commercial, financial, environmental, regulatory and insurance due diligence).
- Timing: agreement announced 27 July 2026; closing expected in Q4 2026, subject to customary regulatory approvals.
W
White Bridge Investments and other existing shareholders
Seller counsel
Seller counsel not yet recorded
Overview
- Target: Numantec, headquartered in Viadana (Mantua), Italy - a global developer, manufacturer and distributor of infusion medical devices, from vascular access devices and infusion sets through elastomeric and electronic pumps to pre-filled syringes. About 600 employees and seven manufacturing facilities across Europe and the United States.
- History: a buy-and-build platform assembled by White Bridge Investments from Delta Med, the Italian vascular-access specialist it acquired in October 2021, and extended through acquisitions including Health Line International Corp. (United States, January 2025). CEO Gabriele Giovanelli: 'in Goldman Sachs Alternatives we have found a partner who understands our sector, shares our ambition and brings the resources' to support the next phase of growth. No revenue or earnings figures have been published.
- Seller: White Bridge Investments, the Milan-based private equity investor and main shareholder, together with other existing shareholders. Chairman Marco Pinciroli: 'The next chapter calls for greater scale and investment capacity.'
- Seller and target counsel: White & Case, led by partners Michael Immordino (London and Milan) and Leonardo Graffi (Milan and London) with associates Elena Ruggiu, Valerio Bianchi and Nicola Acconcia and trainees Mario Vita and Andrea Coppola (Milan). Foreign direct investment: Orion Berg, Louis Roussier (Paris). Antitrust: Giuseppe Tantulli, Roberto Giorgetti (Brussels). Intellectual property: Dan Reavill, Veronica Pagnoni (London).
- Further seller counsel: Giovannelli e Associati, coordinated by partner Matteo Delucchi with partner Andrea Mossa and associate Federico Simone Coscia; Gatti Pavesi Bianchi Ludovici for White Bridge Investments, with equity partner Michele Aprile and junior partner Roger Demoro.
- Financial advisers: J.P. Morgan (sole M&A adviser to Numantec and White Bridge); Houlihan Lokey (debt advisory: Matteo Manfredi, Vieri Betti Guaraldi, Marco Mezzadri, Marco Mollura). Other sell-side advisers: BCG, Deloitte, Plante Moran, ERM, Intexo and Willis Towers Watson.